DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Lung Diseases D008171 37 associated lipids
Peritonitis D010538 38 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Hypotension D007022 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Psoriasis D011565 47 associated lipids
Precancerous Conditions D011230 48 associated lipids
Fatty Liver D005234 48 associated lipids
Thrombosis D013927 49 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Levant B et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats. 2008 Psychoneuroendocrinology pmid:18707812
Mitsuhashi N and Kato J Modulation of steroid hormone receptors in the brain--inhibitory effect of fatty acids on the binding between cytosol progestin receptors in the rat cortex and R5020. 1987 Psychoneuroendocrinology pmid:2955444
Rees AM et al. Omega-3 deficiency associated with perinatal depression: case control study. 2009 Psychiatry Res pmid:19268372
Parker GB et al. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. 2006 Psychiatry Res pmid:16499974
Lucas M et al. Plasma omega-3 and psychological distress among Nunavik Inuit (Canada). 2009 Psychiatry Res pmid:19394089
Kale A et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. 2010 Psychiatry Res pmid:19969375
Buydens-Branchey L and Branchey M Long-chain n-3 polyunsaturated fatty acids decrease feelings of anger in substance abusers. 2008 Psychiatry Res pmid:17900705
McNamara RK et al. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. 2008 Psychiatry Res pmid:18715653
Conklin SM et al. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. 2007 Psychiatry Res pmid:17383013
Mischoulon D and Freeman MP Omega-3 fatty acids in psychiatry. 2013 Psychiatr. Clin. North Am. pmid:23538073
Nadalin S et al. Niacin skin flush test: a research tool for studying schizophrenia. 2010 Psychiatr Danub pmid:20305586
Buretić-Tomljanović A et al. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia. 2008 Psychiatr Danub pmid:18827766
Shaikh IA et al. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. 2008 Prostate pmid:18668525
Cavazos DA et al. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. 2011 Prostate pmid:21360560
Westphal C et al. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease? 2011 Prostaglandins Other Lipid Mediat. pmid:21945326
Weylandt KH et al. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. 2012 Prostaglandins Other Lipid Mediat. pmid:22326554
Giudetti AM and Cagnazzo R Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases. 2012 Prostaglandins Other Lipid Mediat. pmid:23064030
Kim HY et al. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. 2011 Prostaglandins Other Lipid Mediat. pmid:21810478
Recchiuti A Resolvin D1 and its GPCRs in resolution circuits of inflammation. 2013 Prostaglandins Other Lipid Mediat. pmid:23500003
Gladyshev MI et al. Production of EPA and DHA in aquatic ecosystems and their transfer to the land. 2013 Prostaglandins Other Lipid Mediat. pmid:23500063
Serhan CN et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. 2004 Prostaglandins Other Lipid Mediat. pmid:15290791
Wagner K et al. Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. 2011 Prostaglandins Other Lipid Mediat. pmid:21854866
von Schacky C The Omega-3 Index as a risk factor for cardiovascular diseases. 2011 Prostaglandins Other Lipid Mediat. pmid:21726658
Monia ZA et al. Docosahexaenoic acid reduces both cyclic nucleotide and melatonin synthesis in rat pinealocytes. 1998 Prostaglandins Other Lipid Mediat. pmid:9653768
Rapoport SI et al. Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. 2011 Prostaglandins Other Lipid Mediat. pmid:21704722
Taber DF and Jackson Roberts L Nomenclature systems for the neuroprostanes and for the neurofurans. 2005 Prostaglandins Other Lipid Mediat. pmid:16303600
Hong S et al. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis. 2005 Prostaglandins Other Lipid Mediat. pmid:16303609
Yuan J et al. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. 2010 Prostaglandins Other Lipid Mediat. pmid:20394833
Seki H et al. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. 2009 Prostaglandins Other Lipid Mediat. pmid:19737659
Hishinuma T et al. Effects of long-term supplementation of eicosapentanoic and docosahexanoic acid on the 2-, 3-series prostacyclin production by endothelial cells. 1999 Prostaglandins Other Lipid Mediat. pmid:10480487
Shi H et al. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. 2016 Prostaglandins Other Lipid Mediat. pmid:27026343
Niemoller TD and Bazan NG Docosahexaenoic acid neurolipidomics. 2010 Prostaglandins Other Lipid Mediat. pmid:19804838
Zhang J et al. Characteristics of fatty acid distribution is associated with colorectal cancer prognosis. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23465412
Kuipers RS et al. High contents of both docosahexaenoic and arachidonic acids in milk of women consuming fish from lake Kitangiri (Tanzania): targets for infant formulae close to our ancient diet? 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:15763440
Cunnane SC Commentary on the workshop statement. Essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10991770
Burdge GC Metabolism of alpha-linolenic acid in humans. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16828546
Das UN et al. Effect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728172
Maki KC et al. Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic β-cell response in subjects with primary hypertriglyceridemia. 2011 Sep-Oct Prostaglandins Leukot. Essent. Fatty Acids pmid:21775113
Xi S et al. Suppression of proto-oncogene (AP-1) in a model of skin epidermal hyperproliferation is reversed by topical application of 13-hydroxyoctadecadienoic acid and 15-hydroxyeicosatrienoic acid. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10765974
Sala-Vila A et al. Influence of dietary source of docosahexaenoic and arachidonic acids on their incorporation into membrane phospholipids of red blood cells in term infants. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16326086
Kawabata T et al. Age-related changes of dietary intake and blood eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid levels in Japanese men and women. 2011 May-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:21420843
Mathieu G et al. Synergistic effects of stress and omega-3 fatty acid deprivation on emotional response and brain lipid composition in adult rats. 2008 Prostaglandins Leukot. Essent. Fatty Acids pmid:18579362
Green P et al. Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology. 2009 Prostaglandins Leukot. Essent. Fatty Acids pmid:19342208
Wiest MM et al. Plasma fatty acid profiles in autism: a case-control study. 2009 Prostaglandins Leukot. Essent. Fatty Acids pmid:19307110
De Caterina R et al. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. 1995 Feb-Mar Prostaglandins Leukot. Essent. Fatty Acids pmid:7540306
Kuipers RS et al. Gestational age dependent changes of the fetal brain, liver and adipose tissue fatty acid compositions in a population with high fish intakes. 2012 Prostaglandins Leukot. Essent. Fatty Acids pmid:22425685
Marcheselli VL et al. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. 2010 Prostaglandins Leukot. Essent. Fatty Acids pmid:19931440
Serhan CN Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. 2008 Sep-Nov Prostaglandins Leukot. Essent. Fatty Acids pmid:19008087
Sethom MM et al. Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia. 2010 Prostaglandins Leukot. Essent. Fatty Acids pmid:20667702
Das UN et al. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9482165